Medications for Rheumatoid Arthritis

373 results

  • Abrilada (adalimumab-afzb)

    (adalimumab-afzb)
    Pfizer Laboratories Div Pfizer Inc
    Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients 2 years and older.

  • Adalimumab (adalimumab)

    (adalimumab)
    Golden State Medical Supply, Inc.
    Usage: Adalimumab-fkjp is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It reduces symptoms, inhibits structural damage progression, and improves physical function in affected patients.

  • Amjevita (adalimumab-atto)

    (adalimumab-atto)
    Optum Health Solutions (Ireland) Limited
    Usage: AMJEVITA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. It can be used alone or with other therapies.

  • Azathioprine (azathioprine)

    (Azathioprine)
    Ascend Laboratories, LLC
    Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal homotransplantation and for managing active rheumatoid arthritis to reduce signs and symptoms. Its combined use with other disease-modifying anti-rheumatic drugs has not been studied and is not recommended.

  • Azathioprine (azathioprine)

    (Azathioprine)
    Glenmark Pharmaceuticals, Inc
    Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal transplants and for managing active rheumatoid arthritis to reduce signs and symptoms. Its use with disease-modifying anti-rheumatic drugs has not been studied, and concurrent use is not recommended.

  • Baycadron (dexamethasone)

    (Dexamethasone)
    Wockhardt USA, LLC
    Usage: This drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., arthritis), collagen diseases, dermatologic diseases, severe allergic reactions, ophthalmic inflammation, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and special cases like tuberculous meningitis and trichinosis.

  • Beta 1 kit (betamethasone sodium phosphate, betamethasone acetate)

    (Betamethasone Sodium Phosphate, Betamethasone Acetate)
    Oaklock, LLC
    Usage: Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated for severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neurologic conditions, and various inflammatory diseases. It serves as adjunctive therapy for specific acute episodes and can be used intramuscularly, intra-articularly, or intralesionally.

  • Celebrex

    (Celecoxib)
    PFIZER LABORATORIES DIV PFIZER INC
    Usage: CELEBREX is indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients aged 2 and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

  • Celebrex (celecoxib)

    (CELECOXIB)
    Proficient Rx LP
    Usage: CELEBREX is indicated for the relief of signs and symptoms associated with osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (ages 2+), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea. Use should be at the lowest effective dose for the shortest duration consistent with treatment goals.

  • Celebrex (celecoxib)

    (Celecoxib)
    Viatris Specialty LLC
    Usage: CELEBREX is indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients aged 2 and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.